Patients with advanced-stage classic Hodgkin lymphoma had a longer progression-free survival rate with Opdivo plus AVD, a chemotherapy regimen, compared with Adcetris plus AVD.
Related Keywords
California , United States , Alexf Herrera , , International Prognostic Score , Non Hodgkin Lymphoma , Asco Annual Conference ,
vimarsana.com © 2020. All Rights Reserved.